These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 22662015)

  • 21. Current medical therapies for patients with peripheral arterial disease: a critical review.
    Regensteiner JG; Hiatt WR
    Am J Med; 2002 Jan; 112(1):49-57. PubMed ID: 11812407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent Claudication.
    Hirsch AT; M Reich L
    Curr Treat Options Cardiovasc Med; 2001 Jun; 3(3):167-180. PubMed ID: 11341862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How To Assess a Claudication and When To Intervene.
    Hossain P; Kokkinidis DG; Armstrong EJ
    Curr Cardiol Rep; 2019 Nov; 21(12):138. PubMed ID: 31728766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical and lifestyle management of peripheral arterial disease.
    Parvar SL; Fitridge R; Dawson J; Nicholls SJ
    J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do we have a unified consensus on antithrombotic management of PAD?
    Poredos P; Antignani PL; Blinc A; Fras Z; Jezovnik MK; Fareed J; Mansilha A
    Int Angiol; 2021 Jun; 40(3):229-239. PubMed ID: 33739074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive cardiac rehabilitation program for peripheral arterial diseases.
    Yasu T
    J Cardiol; 2022 Oct; 80(4):303-305. PubMed ID: 34857431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy insight: peripheral arterial disease and diabetes--from pathogenesis to treatment guidelines.
    Mohler ER
    Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):151-62. PubMed ID: 17330127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR
    J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment.
    Firnhaber JM; Powell CS
    Am Fam Physician; 2019 Mar; 99(6):362-369. PubMed ID: 30874413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel-Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events.
    Kalantzi K; Tentolouris N; Melidonis AJ; Papadaki S; Peroulis M; Amantos KA; Andreopoulos G; Bellos GI; Boutel D; Bristianou M; Chrisis D; Dimitsikoglou NA; Doupis J; Georgopoulou C; Gkintikas SA; Iraklianou S; Kanellas Κ; Kotsa K; Koufakis T; Kouroglou M; Koutsovasilis AG; Lanaras L; Liouri E; Lixouriotis C; Lykoudi A; Mandalaki E; Papageorgiou E; Papanas N; Rigas S; Stamatelatou MI; Triantafyllidis I; Trikkalinou A; Tsouka AN; Zacharopoulou O; Zoupas C; Tsolakis I; Tselepis AD
    J Am Heart Assoc; 2021 Jan; 10(1):e018184. PubMed ID: 33327737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention.
    Muir RL
    J Vasc Nurs; 2009 Jun; 27(2):26-30. PubMed ID: 19486852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of lower extremity peripheral arterial disease.
    Gardner AW; Afaq A
    J Cardiopulm Rehabil Prev; 2008; 28(6):349-57. PubMed ID: 19008688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cilostazol for intermittent claudication.
    Bedenis R; Stewart M; Cleanthis M; Robless P; Mikhailidis DP; Stansby G
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003748. PubMed ID: 25358850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercholesterolemia. The evidence supports use of statins.
    Aronow WS
    Geriatrics; 2003 Aug; 58(8):18-20, 26-8, 31-2. PubMed ID: 12938249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating patients with peripheral arterial disease and claudication.
    Treat-Jacobson D; Walsh ME
    J Vasc Nurs; 2003 Mar; 21(1):5-14; quiz 15-6. PubMed ID: 12629492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical management of peripheral arterial disease: a therapeutic algorithm.
    Lumsden AB; Rice TW
    J Endovasc Ther; 2006 Feb; 13 Suppl 2():II19-29. PubMed ID: 16511954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications.
    Manolis AA; Manolis TA; Melita H; Mikhailidis DP; Manolis AS
    J Clin Pharmacol; 2022 Mar; 62(3):320-358. PubMed ID: 34671983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.